Why It’s Good to Be Annoyed
Annoyance is humanity’s most underappreciated emotion. It’s a prickly, uncomfortable feeling that demands attention—your brain’s way
The problem with TAM
Total Addressable Market (TAM) is a ubiquitous metric in biotech investment pitches, used to quantify the theoretical revenue potential of
The Problem with CAGR
Biotech investing is not for the faint-hearted. This field, ruled by unpredictability, is a theatre of sharp turns: clinical trials
Exploring Outliers: How Rare Events Shape My Thinking
Hi, I’m Sebastian, and this blog is both an indulgence and an exploration. It’s not for any one